While operating losses were relatively modest at $30.3 million for the year ended Sept. 30, significant declines in the value of unrealized investments drove the overall loss figure down. The approximately $520 million loss compares with a $1.1 billion net gain for the hospital in 2021.
Kevin Churchwell, MD, president and CEO of the hospital, told Becker’s in late December that 2022 was an unpredictable year and said it was teamwork that was able to see the hospital cope as well as it did.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
